United States, January 11, 2026 -- For decades, businesses have been constrained by expensive toll-free numbers, high international rates, and per-minute charges. Call2 aims to end that era with its ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva's anti-IL-15 candidate, TEV-'408 TE ...
Nanomaterials, Energy Storage, Electrochemical Sensors, Sensing Technologies Share and Cite: Anney, A. and Biswas, S. (2026) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback